Registration
FOLEY HOAG LLP for TRIUS THERAPEUTICS
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) Issues related to antibiotic drug development
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL KIM New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.